These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4188054)

  • 1. Treatment of benign prostatic hyperplasia by phenol injection.
    Angell JC
    Br J Urol; 1969 Dec; 41(6):735-8. PubMed ID: 4188054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy in patients with adenoma of the prostate gland with urination disorders].
    Spivak LG; Vinarov AZ; Evdokimov MS
    Urologiia; 2012; (6):96-9. PubMed ID: 23379250
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment by prostatic injection of acute urinary retention due to prostatic hyperplasia.
    Shipman JJ; Akilie AN
    Br Med J; 1967 May; 2(5549):418-9. PubMed ID: 4164447
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical treatment of prostatic obstruction. An objective assessment.
    Claridge M
    Invest Urol; 1975 Mar; 12(5):401-4. PubMed ID: 46221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
    Urologiia; 2005; (5):25-6. PubMed ID: 16281835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urinary retention.
    Shipman JJ; Newman BM; Morris G; Misch KA
    Br Med J; 1974 Sep; 3(5933):734-5. PubMed ID: 4138025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia.
    Resnick MI; Jackson JE; Watts LE; Boyce WH
    J Urol; 1983 Jan; 129(1):206-9. PubMed ID: 6186824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of lower urinary tract symptoms and use of doxazosin in the treatment of early stages of benign prostate hyperplasia].
    Nurullaev RB
    Lik Sprava; 2004; (3-4):101-3. PubMed ID: 15318840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?
    Morgia G
    Eur Urol; 2011 Mar; 59(3):353-5; discussion 355. PubMed ID: 21130562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment.
    de la Rosette JJ
    Urology; 2010 Jun; 75(6):1458. PubMed ID: 20513508
    [No Abstract]   [Full Text] [Related]  

  • 13. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of urinary retention due to benign prostatic hyperplasia using luteinizing hormone-releasing hormone agonist.
    Schlegel PN; Brendler CB
    Urology; 1989 Aug; 34(2):69-72. PubMed ID: 2474882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment to short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gravas S
    Int J Urol; 2010 Oct; 17(10):875. PubMed ID: 20887633
    [No Abstract]   [Full Text] [Related]  

  • 17. The significance of perineal pain after injection of the prostate.
    Broughton AC; Smith PH
    Br J Urol; 1970 Feb; 42(1):73-5. PubMed ID: 4190964
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-operative treatment of benign prostatic hyperplasia.
    Lal MM; Jain S
    J Indian Med Assoc; 1980 Nov; 75(9):174-6. PubMed ID: 6164733
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diclofenac sodium therapy in irritating micturition syndrome following TUR for benign prostatic hyperplasia].
    Soler Roselló A; Morote Robles J; García Rojo D; Vila Barja J; Prera Vilaseca A
    Arch Esp Urol; 1990 Oct; 43(8):831-5. PubMed ID: 1705414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.